Table 3:
Age-dependent regulation of ACE2, TMPRSS2 and apoptosis in human lung
| Human age: | 0–30 days (Newborn) | 1–12 months (Infant) | 1–17 years (Child) | 18–45 years (Adult) | 45–64 years (Late Adult) | 65–74 years (Elderly) | 75+ (Advanced Age) | |
|---|---|---|---|---|---|---|---|---|
| ACE2 mRNA Lung Epithelial | Low | Moderate/High | Moderate | Moderate | Not available | Not available | Not available | |
| ACE2 mRNA Lung Endothelial | None | None | None | Low | Not available | Not available | Not available | |
| ACE2 in Lung Cells | All (DAPI+) | Not available | High | Low, variable | Moderate, variable | Moderate, variable | High, variable | High, variable |
| AQP3+ | Not available | Not available | Moderate, variable | Moderate, variable | Moderate, variable | Moderate, variable | Moderate, variable | |
| PDPN+ | Not available | Not available | Low, variable | Moderate, variable | Moderate, variable | High, variable | High, variable | |
| TMPRSS2 mRNA Lung Epithelial | None | Moderate | Low | Low | Not available | Not available | Not available | |
| TMPRSS2 mRNA Lung Endothelial | None | None | None | Low | Not available | Not available | Not available | |
| Apoptotic Priming | Not available | Not available | Not available | Not available | Not available | Not available | Not available | |
| BCL-2 Family Gene Expression | Pore-Forming | Moderate | Moderate | Moderate | Moderate | Not available | Not available | Not available |
| Pro-Apoptotic | Moderate | Moderate | Moderate | Low | Not available | Not available | Not available | |
| Pro-Survival | Moderate | Moderate | Moderate | High | Not available | Not available | Not available | |